Page 17 - AWA Vol.41-No.2
P. 17

ANIMAL HEALTH

               Elanco Launches Novel Multi-Species Treatment

                           for Livestock Respiratory Diseases

            lanco Animal Health  Incorporated
         Eannounced the availability of its lat-
        est innovation: Pradalex™ (pradofloxacin
        injection) for the treatment of bovine respi-
        ratory disease (BRD) respiratory disease
        (SRD). Pradalex is the first new molecule
        and injectable antibiotic treatment to be
        approved by the U.S. Food and Drug Ad-
        ministration (FDA) to treat BRD and SRD in
        roughly two decades. In the cattle industry,
        BRD — or “shipping fever” — is one of the
        most frequent and costly stocker and feed-
        lot diseases, affecting the health and well-
        being of animals and potentially costing
        producers $1 billion annually. Similarly, SRD
        is the most prevalent cause of nursery and
        grow-finish pig deaths in the U.S., creating
        substantial production and economic loss-  multocida, Mycoplasma hyopneumoniae,   ment gilts and sows intended for breeding)
        es for producers and accounting for addi-  Glaesserella (Haemophilus) parasuis .  and in nursing piglets.
        tional annual costs of up to $5 perlivestock..  Pradalex is rapidly absorbed and distrib-  “At Elanco, we focus on bringing produc-
         “The launch of Pradalex further demon-  uted at the injection site, reaching a high   ers a broad portfolio of solutions to support
        strates Elanco’s commitment to bring new   and effective therapeutic concentration in   their disease prevention efforts, starting
        tools and innovations that help address   plasma within 45 minutes of administration   with vaccines and feed additives that opti-
        some of our customers’ biggest challeng-  to cattle and a high maximum therapeu-  mize the health outcomes of calves.,” says
        es,” says Dr. José Manuel Correia de Simas,   tic concentration in cattle lung pulmonary   Dr. Ronald Tessman, Elanco beef technical
        Executive Vice President, U.S. Farm Animal   epithelial lining fluid within six hours. This   consultant.  “When antibiotics  are neces-
        at Elanco. “Pradalex is a new molecule with   aids in the fast in-vitro elimination of bac-  sary, Elanco has a full range to fit produc-
        a novel mode of action that treats respirato-  teria and limits lung damage in both cattle   ers’ needs. Pradalex is our newest antibiotic
        ry diseases in beef and swine, strengthen-  and swine. Its novel pharmacokinetic and   and is truly different from any other product
        ing our portfolio of solutions and providing   pharmacodynamic profile reduces the time   on the market, giving producers another
        veterinarians and producers with multiple   needed to select resistant bacteria, contrib-  valuable tool that can be used in an inte-
        choices to prevent and control respiratory   uting to judicious antibiotic use.  grated approach to reducing losses due to
        challenges.”
                                             “Pradalex combines a high plasma peak   BRD.”
         Pradalex is a convenient single-dose, low-  concentration reached very quickly with
        volume  antibiotic  with excellent  syringe-  a unique mode of action, resulting in com-  Pradalex is indicated for the treatment of
        ability and an industry-leading withdrawal   prehensive coverage of Gram-positive and   BRD in beef cattle (calves two months of age
        period. Pradalex’s structural differences   Gram-negative pathogens,” comments Dr.   and over, steers, heifers and bulls intended
        result in a dual targeting effect, yielding im-                         for slaughter and replacement heifers and
        proved potency compared to similar antibi-  Pat Hoffmann, Elanco Swine Technical Con-  bulls intended for breeding and less than
        otics. Pradalex is indicated for the treatment   sultant. “It makes an exceptional option for   one year of age) and dairy cattle (replace-
        of BRD and SRD and kills major BRD and   a spot treatment injectable intervention.”  ment heifers and bulls less than one year
        SRD bacteria, including Mannheimia hae-  Pradalex is indicated for the treatment of   of age). It is not for use in male and female
        molytica, Pasteurella multocida, Histophi-  SRD in weaned swine intended for harvest.   cattle intended for breeding that are over
        lus somni and Mycoplasma bovis in cattle   It is not for use in swine intended for breed-  one year of age, in calves under two months
        and Bordetella bronchiseptica, Pasteurella   ing (boars intended for breeding, replace-  of age or in veal calves.  Circle 21 on enquiry card


            Hopper Batching Controller with Superior Accuracy

             inTrac is pleased to introduce the   The controller software is self-learning
          BNEW Hopper Batching Controller &   with early shut-off detection to automati-
          Scale Indicator, offering superior batch-  cally adjust for free-fall material to opti-
          ing accuracy.                     mize batching accuracy.
           Perfect for improving productivity   Combined with our precision S-type
          and accuracy in your operations, the H-  load cells, the H-BTB200 system can dis-
          BTB200 controller/indicator features an   play the feed hopper weight and the tar-
          LED bar graph that provides a quick visu-  get batch amount in 0.1lb increments.
          al status of the batching process and can   The entire BinTrac system is designed
          also display information about the last 10   to be reliable, low-maintenance, and easy
          completed batches.                to operate.        Circle 22 on enquiry card



                                                                                                      Vol. 41 No. 2   15
   12   13   14   15   16   17   18   19   20   21   22